HRT prescribing protocols and templates in both EMIS and SystmOne are being updated to reflect the latest BMS guidance. Oestrogen and progestogen options will now be clearly marked as low, medium, or high dose, with new information boxes to alert prescribers when high dose oestrogen is selected. Protocols and templates will include updated dose ranges and clear notes about off-label use, ensuring prescribers have the right information to adjust progestogen doses for patient safety.